Corporate

4
Jan

Genoskin CSO obtains high-profile career award

GENOSKIN CSO OBTAINS HIGH-PROFILE CAREER AWARD To start the new year in good cheer, Genoskin is proud to announce that Dr. Nicolas Gaudenzio, our Chief Scientific Officer and Principal Investigator at Infinity, has recently obtained the Arloing-Courmont-Pasteur Institute career achievement award in human biology from the Academy of Science in Lyon, France. An award to highlight innovative scientific research The
Read more
8
Nov

PRESS RELEASE – Dr. Nicolas Gaudenzio is appointed Chief Scientific Officer at Genoskin

Dr. Gaudenzio is a world-renowned researcher and expert in immunology and allergic skin inflammation. He is also principal investigator and leader of a research group at the Infinity Institute (Toulouse Institute for Infectious and Inflammatory Diseases, France), which focuses on the neuronal regulation of immune response.

9
Jun

Interview with Pr. Guy Serre

10 Year Anniversary: Interview with Pr. Guy Serre For our 10th anniversary, we spoke to people who helped Genoskin become what it is today. Back in March, we had a chat with Pr. Guy Serre, Director of the UDEAR lab (Epidermis Differentiation and Rheumatoid Autoimmunity Unit), the place where Genoskin was born. Genoskin: Could you describe the relationship between your
Read more
6
Jul

Brand new sustainable and user-friendly packaging!

Brand new sustainable and user-friendly packaging! After months of reflection, design trials, and careful sourcing, Genoskin is proud to reveal its brand new packaging. Thanks to Marta Wolska-Brys (Packaging & Beyond, LLC) and her expert support we designed our dream packaging. You will soon get to see it in your labs! It’s awesome! We designed this new packaging with your
Read more
16
May

Genoskin featured in a Business Insider article

Genoskin featured in a Business Insider article The press is talking about Genoskin! Amid COVID-19 breakout, Genoskin got attention from Business Insider 's reporter Mia Jankowicz.  We recently communicated on our continued efforts during the pandemic and our preferred access program for research on COVID-19. Genoskin's projects and technology caught the eye of Mia Jankowicz. Mia, a journalist specializing in
Read more
10
Feb

Genoskin reinforces R&D capabilities

Genoskin reinforces R&D capabilities Genoskin Research & Development offers new services to portfolio available to partners with the addition of new equipment. Genoskin's R&D recently added a Meso Scale QuickPlex SQ120 for high-performance electroluminescence immunoassays. This new instrument will enable our teams to detect the presence of biomarkers down to femtoscale concentrations. Genoskin also added a best-in-class solar simulator (Solar Light) capable of
Read more